Patented Products 
 Oncology Formulations
  Therapeutic
    
Segments

 Anaesthetics

 Anthelmintic

 Anti Hypertensives

 Anti- Ulcler Agents

 Anti-Asthamatic

 Anti-Diabetic

 Anti-Fungal

 Anti-Histamines

 Anti-Microbials

 Anti-Tussives

 Drugs In Osteoporosis

 Haematinic And Nutritional Supplement

 NSAIDs

 Skeletal Muscle Relaxants

 Oncology API
 Specialty APIs
 Chiral intermediates
Anti Hypertensives
Amlonol tablet Amlodipine 5mg + Atenolol 50mg
Converten 2.5 mg tablet Each uncoated tablet contains:Enalapril Maleate I.P. 2.5 mg
Lonol-25 mg tablet Each uncoated tablet contains:Atenolol I.P. 25 mg
Rachet Ramipril 2.5mg + HCT 12.5mg
Strok rok Losartan 50mg + HCT 12.5mg
Vasteze Atorvastatin 10mg + Ezetimibe 10mg
Converten 5.0 mg tablet Each uncoated tablet contains:Enalapril Maleate I.P. 5 mg
Converten 10.0 mg tablet Each uncoated tablet contains:Enalapril Maleate I.P. 10 mg
Lonol-50 mg tablet Each uncoated tablet contains:Atenolol I.P 50 mg
Lonol-100mg tablet Each uncoated tablet contains:Atenolol I.P. 100 mg
 

Present

Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

  

Future

Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)

 
   
© 2001 - 2007 Khandelwal Laboratories Pvt. Ltd. All rights reserved.